Longboard Pharmaceuticals Statistics
Total Valuation
ACR has a market cap or net worth of $268.56 million. The enterprise value is $1.58 billion.
Important Dates
The last earnings date was Wednesday, July 30, 2025, after market close.
| Earnings Date | Jul 30, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ACR has 13.64 million shares outstanding. The number of shares has decreased by -8.29% in one year.
| Current Share Class | 13.64M |
| Shares Outstanding | 13.64M |
| Shares Change (YoY) | -8.29% |
| Shares Change (QoQ) | -1.52% |
| Owned by Insiders (%) | 2.12% |
| Owned by Institutions (%) | 29.48% |
| Float | 6.53M |
Valuation Ratios
The trailing PE ratio is 831.45 and the forward PE ratio is 37.15.
| PE Ratio | 831.45 |
| Forward PE | 37.15 |
| PS Ratio | 1.69 |
| Forward PS | 4.53 |
| PB Ratio | 0.32 |
| P/TBV Ratio | 0.64 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 16.40 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 4,893.75 |
| EV / Sales | 18.25 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 60.21, with a Debt / Equity ratio of 3.11.
| Current Ratio | 60.21 |
| Quick Ratio | 51.23 |
| Debt / Equity | 3.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 4.77%.
| Return on Equity (ROE) | 4.77% |
| Return on Assets (ROA) | 1.07% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | $21.65M |
| Profits Per Employee | $80,750 |
| Employee Count | 4 |
| Asset Turnover | 0.04 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ACR has paid $155,000 in taxes.
| Income Tax | 155,000 |
| Effective Tax Rate | 0.73% |
Stock Price Statistics
The stock price has increased by +29.88% in the last 52 weeks. The beta is 1.78, so ACR's price volatility has been higher than the market average.
| Beta (5Y) | 1.78 |
| 52-Week Price Change | +29.88% |
| 50-Day Moving Average | 18.26 |
| 200-Day Moving Average | 18.20 |
| Relative Strength Index (RSI) | 65.90 |
| Average Volume (20 Days) | 27,427 |
Short Selling Information
The latest short interest is 272,962, so 2.00% of the outstanding shares have been sold short.
| Short Interest | 272,962 |
| Short Previous Month | 55,288 |
| Short % of Shares Out | 2.00% |
| Short % of Float | 4.18% |
| Short Ratio (days to cover) | 3.44 |
Income Statement
In the last 12 months, ACR had revenue of $86.60 million and earned $323,000 in profits. Earnings per share was $0.04.
| Revenue | 86.60M |
| Gross Profit | 32.28M |
| Operating Income | 11.68M |
| Pretax Income | 25.90M |
| Net Income | 323,000 |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | $0.04 |
Full Income StatementBalance Sheet
The company has $42.75 million in cash and $1.35 billion in debt, giving a net cash position of -$1.31 billion or -$96.20 per share.
| Cash & Cash Equivalents | 42.75M |
| Total Debt | 1.35B |
| Net Cash | -1.31B |
| Net Cash Per Share | -$96.20 |
| Equity (Book Value) | 435.40M |
| Book Value Per Share | 62.41 |
| Working Capital | 1.66B |
Full Balance SheetCash Flow
| Operating Cash Flow | 16.38M |
| Capital Expenditures | -114,000 |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 37.27%, with operating and profit margins of 13.49% and 25.03%.
| Gross Margin | 37.27% |
| Operating Margin | 13.49% |
| Pretax Margin | 24.39% |
| Profit Margin | 25.03% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ACR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 8.29% |
| Shareholder Yield | 8.29% |
| Earnings Yield | 0.12% |
| FCF Yield | n/a |
Dividend DetailsAnalyst Forecast
The average price target for ACR is $17.50, which is -11.12% lower than the current price. The consensus rating is "Buy".
| Price Target | $17.50 |
| Price Target Difference | -11.12% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on February 17, 2021. It was a reverse split with a ratio of 1:3.
| Last Split Date | Feb 17, 2021 |
| Split Type | Reverse |
| Split Ratio | 1:3 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |
